treatment of lung cancer after first metastasis
Showing 1 - 25 of >10,000
Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)
Recruiting
- Brain Metastases, Adult
- +2 more
- Silibinin
- Placebo
-
Messina, Italy
- +4 more
Jan 9, 2023
Non-small Cell Lung Cancer With Central Nervous System
Recruiting
- Lung Cancer With Central Nervous System Metastasis
- lung cancer with brain /leptomeningeal metastasis
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 4, 2023
NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +2 more
- (no location specified)
Mar 27, 2023
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
NSCLC, Brain Tumors Trial (bevacizumab, First-Line Chemotherapy Agents, Second-Line Chemotherapy Agents)
Completed
- Non-Small Cell Lung Cancer
- Brain Neoplasms
- bevacizumab
- +2 more
- (no location specified)
Dec 9, 2022
PET-CT Predicting Segement Specific Lymph Nodes Metastasis
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Shanghai, ChinaShanghai Cancer Center
Jul 23, 2023
Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +
Recruiting
- Limited Stage Small Cell Lung Cancer
- Not Progressed After First-line Chemoradiotherapy
- TQB2450 Injection + Anlotinib Hydrochloride Capsules
-
Jinan, Shandong, ChinaCancer Hospital Affiliated to Shandong First Medical University
Jul 5, 2023
Cancer Patients Trial in Jinan (Low-dose radiotherapy combined with conventional fractionated radiotherapy)
Recruiting
- Cancer Patients
- Low-dose radiotherapy combined with conventional fractionated radiotherapy
-
Jinan, In Shandong Province, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Jun 7, 2023
NSCLC With EGFR Mutation, Brain Metastases Trial in China (Keynatinib)
Recruiting
- Non-Small Cell Lung Cancer With EGFR Mutation
- Brain Metastases
-
Beijing, Beijing, China
- +4 more
Apr 17, 2022
Circulating Tumor DNA and T Cell Repertoire Predict
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Brain Metastases
- Whole-brain radiotherapy
-
Wuhan, Hubei, ChinaUnion hospital
Feb 12, 2023
Brain Metastases, NSCLC Trial in Shanghai (EGFR-TK Inhibitor, Stereotactic radiotherapy)
Recruiting
- Brain Metastases
- Non-small Cell Lung Cancer
- EGFR-TK Inhibitor
- Stereotactic radiotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 27, 2023
Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR
Not yet recruiting
- Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
- +6 more
- (no location specified)
Aug 9, 2022
Lung Cancer, Metastatic Cancer Trial in Detroit (Cryotherapy (PTC), Prednisone)
Completed
- Lung Cancer
- Metastatic Cancer
- Cryotherapy (PTC)
- Prednisone
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Oct 29, 2022
NSCLC Trial in Wuhan (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)
Recruiting
- Non-small Cell Lung Cancer
- Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel
-
Wuhan, Hubei, ChinaUnion hospital
Feb 20, 2023
Non Small Cell Lung Cancer Trial in Hangzhou (Furmonertinib Mesilate Tablets)
Enrolling by invitation
- Non Small Cell Lung Cancer
- Furmonertinib Mesilate Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Apr 3, 2023
Lung Cancer Trial in Shanghai (Biopsy (baseline), Biopsy (optional, after treatment), Biopsy (optional, relapse and metastasis))
Not yet recruiting
- Lung Cancer
- Biopsy (baseline)
- +2 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
May 11, 2023
Stratification for Lung Metastasis in Colorectal Cancer
Completed
- Colorectal Cancer
- Lung Metastases
- The location of the patient's treatment
- (no location specified)
Apr 5, 2023
Occult Nodal Metastasis of Clinical N0 Lung Cancer
Recruiting
- Non-small Cell Lung Cancer
- PET/CT-based Deep Learning Signature
-
Zunyi, Guizhou, China
- +3 more
Jun 22, 2022
Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,
Not yet recruiting
- Lung Cancer
- +2 more
- Durvalumab + carboplatin/cisplatin + etoposide
- +2 more
- (no location specified)
Aug 3, 2022
EGFR Mutant Advanced NSCLC Trial (BBT-207)
Not yet recruiting
- EGFR Mutant Advanced Non-Small Cell Lung Cancer
- (no location specified)
Jun 16, 2023
Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)
Not yet recruiting
- Non Small Cell Lung Cancer
- Brain Metastases
- (no location specified)
Apr 2, 2023
NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic
Not yet recruiting
- NSCLC
- +5 more
- single fraction stereotactic radiosurgery (SSRS)
- fractionated stereotactic radiosurgery (FSRS)
- (no location specified)
Jan 18, 2023
Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +
Recruiting
- Melanoma
- +14 more
- LITT + Pembrolizumab
-
Gainesville, Florida
- +1 more
Aug 22, 2022
Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)
Not yet recruiting
- Small Cell Lung Cancer Limited Stage
- Prophylactic cranial irradiation
- +2 more
- (no location specified)
Dec 14, 2022
Early Metastasis in Cervical Cancer Patients After Radiotherapy
Not yet recruiting
- Cervical Cancer
- +4 more
- external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
Oct 21, 2023